ESTRELLA IMMUNOPHARMA, INC. Income Taxes Paid
ESTRELLA IMMUNOPHARMA, INC. (ESLA) reported Income Taxes Paid of $1.60 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-13
- ESTRELLA IMMUNOPHARMA, INC. income taxes paid, net for the quarter ending 2025-12-31 was $0.00.
- ESTRELLA IMMUNOPHARMA, INC. income taxes paid, net for the quarter ending 2025-09-30 was $0.00.
- ESTRELLA IMMUNOPHARMA, INC. income taxes paid, net for the quarter ending 2025-06-30 was $900.00.
- ESTRELLA IMMUNOPHARMA, INC. income taxes paid, net for the quarter ending 2025-03-31 was $13.00.
- ESTRELLA IMMUNOPHARMA, INC. income taxes paid, net for fiscal 2025 was $913.00.
- ESTRELLA IMMUNOPHARMA, INC. income taxes paid, net for fiscal 2024 was $1.60K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.60K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | $900.00 derived: sum of 3 quarters · filed 2026-08-13 | $913.00 10-K · filed 2026-03-18 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $900.00 derived: sum of 2 quarters · filed 2026-08-13 | $913.00 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $900.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $913.00 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $13.00 10-Q · filed 2026-05-18 | |||
| 2024-12-31 | $42.37K 10-K · filed 2026-03-18 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.60K 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $1.60K 10-Q · filed 2025-08-12 | $1.60K 10-KT · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |